Jpmorgan Chase & Co »

Intra Cellular Therapies shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Intra Cellular Therapies shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0M 27k 73.17
2024-06-30 $3.9M 57k 68.49
2023-12-31 $301k 4.2k 71.62
2020-12-31 $2.5M 80k 31.80
2019-06-30 $2.0M 155k 12.71
2016-09-30 $1.4M 90k 15.24

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Intra Cellular Therapies

Jpmorgan Chase & Co
Simplex Trading
Group One Trading

View all funds holding Intra Cellular Therapies